Dr. Wagner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans St.,Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 443-923-9525Fax+1 443-923-9405
Education & Training
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999
- Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1995
- Johns Hopkins University School of MedicineClass of 1994
Certifications & Licensure
- MD State Medical License 1998 - 2025
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Start of enrollment: 2010 Sep 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 125 citationsConcordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based ModelIn Young Choi, Ho Tae Lim, Kenneth Estrellas, Jyothi Mula, Tatiana V. Cohen
Cell Reports. 2016-06-07 - 27 citationsA Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirse...Olga Mitelman, Hoda Z. Abdel-Hamid, Barry J. Byrne, Anne M. Connolly, Peter Heydemann
Journal of Neuromuscular Diseases. 2021-08-19 - 38 citationsMyositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.Andrew L. Mammen, Livia Casciola-Rosen, Lisa Christopher-Stine, Thomas E. Lloyd, Kathryn R. Wagner
Neurology(R) Neuroimmunology & Neuroinflammation. 2015-12-01
Press Mentions
- Longitudinal Functional and Imaging Outcome Measures in FKRP Limb-Girdle Muscular DystrophyMay 19th, 2020
- Catabasis Pharmaceuticals Provides Update on Global Phase 3 PolarisDMD Trial for Edasalonexent at Parent Project Muscular Dystrophy 25th Annual ConferenceJune 27th, 2019
Professional Memberships
- Member
External Links
- Wagner labhttps://www.thewagnerlab.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: